These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36510678)

  • 21. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
    Mishra A; Rathore AS
    Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors.
    Gao S; Song L; Xu H; Fikatas A; Oeyen M; De Jonghe S; Zhao F; Jing L; Jochmans D; Vangeel L; Cheng Y; Kang D; Neyts J; Herdewijn P; Schols D; Zhan P; Liu X
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.
    Tanimoto S; Itoh SG; Okumura H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment.
    Pauly I; Kumar Singh A; Kumar A; Singh Y; Thareja S; Kamal MA; Verma A; Kumar P
    Curr Pharm Des; 2022; 28(46):3677-3705. PubMed ID: 36345244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
    Elfiky AA
    J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design.
    Shehzadi K; Yu M; Liang J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp.
    Zhou B; Chen D; Zhang T; Song C; Zhang X; Lin L; Huang J; Peng X; Liu Y; Wu G; Li J; Chen W
    Biomed Pharmacother; 2024 Feb; 171():116180. PubMed ID: 38266622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory activity of marine sponge metabolites on SARS-CoV-2 RNA dependent polymerase: virtual screening and molecular dynamics simulation.
    Ali HSHM; Altayb HN; Firoz A; Bayoumi AAM; El Omri A; Chaieb K
    J Biomol Struct Dyn; 2022; 40(20):10191-10202. PubMed ID: 34151745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2.
    Sharma S; Sharma A; Bhattacharyya D; Chauhan RS
    J Biomol Struct Dyn; 2022; 40(24):14096-14114. PubMed ID: 34766880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
    Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
    J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
    Singh R; Bhardwaj VK; Purohit R
    Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods.
    Poustforoosh A; Hashemipour H; Tüzün B; Pardakhty A; Mehrabani M; Nematollahi MH
    Biophys Chem; 2021 May; 272():106564. PubMed ID: 33711743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach.
    Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S
    Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2.
    Ahmed S; Mahtarin R; Ahmed SS; Akter S; Islam MS; Mamun AA; Islam R; Hossain MN; Ali MA; Sultana MUC; Parves MR; Ullah MO; Halim MA
    J Biomol Struct Dyn; 2021 Oct; 39(16):6290-6305. PubMed ID: 32720571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies.
    Arumugam GS; Sen A; Dash SS; Mitra K; Doble M; Rajaraman G; Gummadi SN
    J Biomol Struct Dyn; 2022; 40(22):12358-12379. PubMed ID: 34533107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
    Agrawal N; Goyal A
    Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
    Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
    Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase.
    Zamzami MA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1846-1858. PubMed ID: 35037842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.